(Q34977872)

5 August 2017

title

Intravesical mitomycin C combined with hyperthermia for patients with T1G3 transitional cell carcinoma of the bladder (English)

1 reference

transitional cell carcinoma

5 August 2017

main subject

1 reference

Sarel Halachmi

1

1 reference

5 August 2017

Boaz Moskovitz

2

1 reference

5 August 2017

Massimo Maffezzini

3

1 reference

5 August 2017

Giario Conti

4

1 reference

5 August 2017

Fabrizio Verweij

5

1 reference

5 August 2017

Daniel Kedar

6

1 reference

5 August 2017

Sandro D Sandri

7

1 reference

5 August 2017

Ofer Nativ

8

1 reference

5 August 2017

Renzo Colombo

9

1 reference

5 August 2017

publication date

22 April 2009

1 reference

5 August 2017

1 reference

5 August 2017

volume

29

1 reference

5 August 2017

issue

3

1 reference

5 August 2017

page(s)

259-264

1 reference

The treated natural history of high risk superficial bladder cancer: 15-year outcome

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Multicentric Study Comparing Intravesical Chemotherapy Alone and With Local Microwave Hyperthermia for Prophylaxis of Recurrence of Superficial Transitional Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Thermo-chemotherapy for intermediate or high-risk recurrent superficial bladder cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Treatment options for BCG failures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Stage T1, grade 3 transitional cell carcinoma of the bladder: an unfavorable tumor?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Optimal management of high-risk T1G3 bladder cancer: a decision analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

15-year experience on intravesical therapy of T1G3 urinary bladder cancer: a conservative approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Long-term follow-up of patients with Stage T1 high-grade transitional cell carcinoma managed by Bacille Calmette-Guérin immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Intravesical bacille Calmette-Guérin in Stage T1 grade 3 bladder cancer therapy: a 7-year follow-up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Low-dose BCG instillations in the treatment of stage T1 grade 3 bladder tumours: recurrence, progression and success

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Tumor progression and survival in patients with T1G3 bladder tumors: multicentric retrospective study comparing 94 patients treated during 17 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

T1G3 transitional cell carcinoma of the bladder: recurrence, progression and survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

The influence of thermo-chemotherapy on bladder tumours: an immunohistochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Intravesical gemcitabine in BCG-refractory T1G3 transitional cell carcinoma of the bladder: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

Preliminary European Results of Local Microwave Hyperthermia and Chemotherapy Treatment in Intermediate or High Risk Superficial Transitional Cell Carcinoma of the Bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.02.012

10.1016/J.UROLONC.2009.02.012

7 January 2021

Identifiers

DOI

1 reference

5 August 2017

1 reference